In half a year, three enterprises received investment from Hillhouse Venture Capital, and multi-omics is the future development trend

In recent years, the omics-related industries have developed rapidly, attracting a large number of capital and enterprises to enter

A series of "omics" such as genomics, proteomics, and metabolomics have sprung up, exploring the mysteries of life while also using precision analytical techniques to provide medical services

The size of China's gene sequencing market is increasing, and it is expected to increase to $4.

With the continuous iterative development of gene sequencing concepts and technologies, the market size of China's gene sequencing industry has shown incremental development

According to the data released by BCC Research, the global gene sequencing market size in 2021 is 15.

According to the data of Markets and Markets, from 2015 to 2019, the market size of China's gene sequencing industry grew at an average annual compound growth rate of about 40%, showing an increasing development trend

Policies have helped the development of gene sequencing, and the industry's enthusiasm for investment is high

Gene sequencing industry development planning is intensively mentioned by the national level industry development planning policy, as an emerging high-tech industry, the development of gene sequencing industry has an extremely important role

From 2015 to 2020, China has promulgated policies and regulations related to genomics

Driven by a series of factors such as technology, legal environment, policy and society, the gene sequencing industry is hot

According to Flint Creation data, in 2020, there were 62 gene sequencing financings in China, with a financing amount of 33.

As the head financing event of THE TOP10, 9 enterprises such as BGI Intelligent Manufacturing, Panshengzi, Stone Burning Medicine, ZhidaoDiadia, Zhenhe Technology and so on have raised a total of 16.

There are still bottlenecks in the industry that need to be solved urgently, and multi-omics is the future development trend

Liang Mengmeng, a doctor of pathology biology at the University of Southern California, pointed out in an interview with China Report that there are still several bottlenecks that need to be solved in gene sequencing in China: First, the sample size of the gene database still needs to be further expanded to increase the accuracy of the data interpretation model; Second, on the second-generation sequencing platform, the accuracy of genome data interpretation is still not ideal, and the future three-generation single-molecule sequencing is expected to solve this problem; There is an extreme shortage of compound talents in the field of sequencing services, and there is a lack of knowledge in genomics among doctors practicing in the

The "2022-2027 China Gene Sequencing Industry Market Operation Status and Investment Planning Proposal Report" published by Huajing Industry Research Institute pointed out that there are three main trends in the future development of the gene sequencing industry:

First, the scale and outsourcing of the industry; The instrument platform based on gene sequencing is expensive and the technology iteration is fast, and large-scale sequencing has a strong economic effect and mass stability effect

Second, sequencing capabilities and data analysis capabilities will become key

Third, the speed of technological updates will be accelerated, and more cross-omics services will be involved; With the development of research technologies such as genome, transcriptome, proteome, metabolome and bioinformatics analysis technology, high-throughput multi-omics technology integrating genomics, transcriptome, proteome, metabolome and other research technologies will become a necessary foundation

It is worth mentioning that proteins, as the downstream of genes, can directly regulate the functional molecules of cells, and the corresponding proteomics has also received widespread attention and policy support

In 2021, the "International Proteome Program 2.
0 - Proteomics-Driven Precision Medicine" project was launched, and Chinese scientists led the International Big Science Program, and the Human Proteome Program 2.
0 (HPP 2.
0) - Wise Eye Engineering International Headquarters settled in Guangzhou
.
HPP 2.
0 is expected to promote a new model of multi-omics data-driven precision medicine, resulting in more biomarkers, diagnostic reagents, diagnostic criteria, and therapeutics
with market value.

Resources:

①Smith Yolanda.
“History of Genomics”.
04 May 2022.

②Del Giacco, Luca, and Cristina Cattaneo.
“ Introduction to genomics”.
doi:10.
1007/978-1-60327-216-2_6

(3) Huajing Industry Research Institute "2022-2027 China Gene Sequencing Industry Market Operation Status and Investment Planning Suggestion Report" 2022.
07.
11

(4) "In-depth Analysis Report of China Genomics Industry (2022-2028)" of Bezhes Information Consulting Co.
, Ltd.
, 2022.
06.
22